Literature DB >> 11137579

Intracerebroventricular infusions of TNF-alpha preferentially recruit blood lymphocytes and induce a perivascular leukocyte infiltrate.

T J Seabrook1, J B Hay.   

Abstract

Tumour necrosis factor (TNF)-alpha is important in several central nervous system (CNS) inflammatory diseases, however, its role in the recruitment of leukocytes into the cerebral spinal fluid (CSF) and CNS is incompletely understood. Therefore, we examined the effect of intracerebroventricular (icv) and parenchymal infusions of TNF-alpha on the type of leukocyte, the pool and subset of lymphocytes recruited into CSF and brain parenchyma. Parenchymal injections of 500 ng of recombinant human TNF-alpha did not induce inflammation, whereas an icv infusion of TNF-alpha caused CSF leuckocytosis and a perivascular infiltrate. Twenty-four hours after the icv infusion neutrophils predominated, with CD4+ T cells being the major lymphocyte subset in CSF. By 48 h lymphocytes were the dominant cell type with CD8+ cells surpassing CD4+ cells in both the CSF and the perivascular infiltrate. The labeled recirculating lymphocyte pool prevailed in normal CSF, but after the infusion of TNF-alpha, the blood pool of lymphocytes was preferentially recruited. These results have implications for the immune surveillance of the CNS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137579     DOI: 10.1016/s0165-5728(00)00429-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  Lymph, lymphocytes, and lymphatics.

Authors:  B Ristevski; H Becker; M Cybulsky; T Seabrook; S Bak; E Chan; M Johnston; J B Hay
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus.

Authors:  Leïla Baloul; Serge Camelo; Monique Lafon
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

3.  Correlation of inducible nitric oxide synthase (iNOS) inhibition with TNF-α, caspase-1, FasL and TLR-3 in pathogenesis of rabies in mouse model.

Authors:  B P Madhu; K P Singh; M Saminathan; R Singh; A K Tiwari; V Manjunatha; C Harish; G B Manjunathareddy
Journal:  Virus Genes       Date:  2015-12-21       Impact factor: 2.332

4.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

5.  A novel mechanism of immune regulation: interferon-gamma regulates retention of CD4 T cells during delayed type hypersensitivity.

Authors:  Tim J Seabrook; Paul J Borron; Lisbeth Dudler; John B Hay; Alan J Young
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

6.  Involvement of glutathione as a mechanism of indirect protection against spontaneous ex vivo apoptosis associated with bovine leukemia virus.

Authors:  Teresa Sanchez Alcaraz; Pierre Kerkhofs; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury.

Authors:  Oliver I Schmidt; Maria Cristina Morganti-Kossmann; Christoph E Heyde; Daniel Perez; Ido Yatsiv; Esther Shohami; Wolfgang Ertel; Philip F Stahel
Journal:  J Neuroinflammation       Date:  2004-07-28       Impact factor: 8.322

8.  β₂-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations.

Authors:  Guy Laureys; Sarah Gerlo; Anneleen Spooren; Frauke Demol; Jacques De Keyser; Joeri L Aerts
Journal:  J Neuroinflammation       Date:  2014-01-30       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.